Chondroprotective Effects of a Histone Deacetylase Inhibitor, Panobinostat, on Pain Behavior and Cartilage Degradation in Anterior Cruciate Ligament Transection-Induced Experimental Osteoarthritic Rats
Osteoarthritis (OA) is the most common articular degenerative disease characterized by chronic pain, joint inflammation, and movement limitations, which are significantly influenced by aberrant epigenetic modifications of numerous OA-susceptible genes. Recent studies revealed that both the abnormal...
Main Authors: | Zhi-Hong Wen, Jhy-Shrian Huang, Yen-You Lin, Zhi-Kang Yao, Yu-Cheng Lai, Wu-Fu Chen, Hsin-Tzu Liu, Sung-Chun Lin, Yu-Chi Tsai, Tsung-Chang Tsai, Yen-Hsuan Jean |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/14/7290 |
Similar Items
-
Design and synthesis of diazine-based panobinostat analogues for HDAC8 inhibition
by: Sivaraman Balasubramaniam, et al.
Published: (2020-04-01) -
Antifungal Activity and Potential Mechanism of Panobinostat in Combination With Fluconazole Against Candida albicans
by: Shan Su, et al.
Published: (2020-07-01) -
Clinical developments in the treatment of relapsed or relapsed and refractory multiple myeloma: impact of panobinostat, the first-in-class histone deacetylase inhibitor
by: Redic KA, et al.
Published: (2016-05-01) -
Panobinostat and its combination with 3-deazaneplanocin-A induce apoptosis and inhibit In vitro tumorigenesis and metastasis in GOS-3 glioblastoma cell lines
by: Javier de la Rosa, et al.
Published: (2018-01-01) -
Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies
by: Marinella Zilli, et al.
Published: (2013-07-01)